Skip to navigation Skip to secondary navigation Skip to content

Life Sciences

Australia - Webinar: Opportunities for UK Businesses in Biotech and Pharmaceuticals (Life Sciences)

In 2012, the Australian pharmaceutical market was valued at around £9 billion and forecasted to reach £11 bn by 2016. British companies have a long track record of success in this market, yet significant opportunities remain.

Full Article

 or show all results

13.12.12 UK and industry partnership in action in UK Life Sciences

In the UK, partners work together to support a research and innovation culture that spans sectors and geographies, and supports the creation of a fully integrated life science and healthcare ecosystem that places the patient at the heart of the system.

13.12.12 Vibrant research base in UK Life Sciences

The UK has a heritage of life science discovery that has transformed scientific knowledge and continues to unlock clinical and commercial opportunities.

07.12.12 Life Sciences

UK healthcare industries include innovators and manufacturers of revolutionary medical devices and healthcare consultants who are exporting

07.12.12 USA-TX- Licensing Opportunity for Clostridium difficile Diagnostic

A Texas Medical Research University’s Technology Transfer Department is offering the opportunity for interested companies to licence medical technology for a C. difficile diagnostic worldwide exclusively or non-exclusively.

15.11.12 United States- Texas- Licensing Opportunity for Electrical-Anatomical Imaging Catheter

TX Med Research University’s Technology Transfer Department: opportunity to licence medical technology for Electrical-Anatomical Imaging Catheter, Combines Noncontact Mapping & Intracardiac Echocardiography exclusively or non-exclusively.

02.11.12 UK device offers cancer diagnosis hope

A revolutionary new cancer-diagnosing device is being developed by researchers in the UK.

01.11.12 Advamed Conference Boston USA: October 01-03, 2012

The 6th Annual Advamed Med Tech conference took place in Boston from October 1-3rd 2012, hosted by the Advanced Medical Technology Group (Advamed).

27.09.12 Life Sciences Sector in South Africa

The South African life sciences market is an open door for UK suppliers due to South Africa’s strong political and trading links with most of the rest Africa, South Africa is a natural hub and springboard into other African markets.

18.09.12 Cyclofluidic opens new laboratory

Cyclofluidic has announced the opening of a new laboratory that will be used to make and screen potential drug molecules.

09.08.12 Flexible Medical Packaging Ltd

In late 2009, Lancashire-based Flexible Medical Packaging (FMP) decided to actively pursue overseas markets for a new range of sterile medical products that it was producing under the brand name Medicross Healthcare®